Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents
This review analyses existing literature, including authors' own data, describing the results of clinical trials which assess safety and efficacy of insulin Glargine (Lantus?) in children and adolescents, as well as peculiar features of T1D management in this age group, including the challenge...
Main Author: | Tamara Leonidovna Kuraeva |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2014-07-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/6581 |
Similar Items
-
Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen
by: N V Efremova, et al.
Published: (2015-10-01) -
Assessment of efficiency of application of various analogues of insulin in treatment of diabetes type 2
by: Rodionova T.l., et al.
Published: (2014-09-01) -
Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring
by: Huiying Wang, et al.
Published: (2021-11-01) -
Basal Insulin Initiation in Elderly Patients with Type 2 Diabetes in Taiwan: A Comparison with Younger Patients
by: Ming-Nan Chien, et al.
Published: (2015-09-01) -
Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment
by: Kai‐Jen Tien, et al.
Published: (2019-05-01)